Skip to main content
. 2018 May 3;35(5):671–685. doi: 10.1007/s12325-018-0700-6

Fig. 1.

Fig. 1

Fig. 1

Four-group adherence trajectories for atypical antipsychotics and (a) ACE inhibitors, (b) biguanides, and (c) SSRIs